TNF-α inhibition in the setting of undiagnosed HIV infection: A call for enhanced screening guidelines

Keyphrases

• Screening Guidelines 100%
• HIV Testing 100%
• Undiagnosed HIV Infection 100%
• TNF Inhibition 100%
• Immunosuppression 50%
• Antiretroviral Therapy 50%
• HIV Infection 50%
• CD4 Count 50%
• Hidradenitis Suppurativa 50%
• Inflammatory Bowel Disease 33%
• Kaposi Sarcoma 33%
• Biologic Therapy 33%
• Chronic HIV Infection 33%
• Older MSM 33%
• Rheumatoid Arthritis 16%
• Infliximab 16%
• Adalimumab 16%
• Remission 16%
• Immune Reconstitution 16%
• Arthropathy 16%
• Clinical Practice Guidelines 16%
• Weight Loss 16%
• Rheumatologic Diseases 16%
• Older Women 16%
• HIV-associated 16%
• Methotrexate 16%
• Inflammatory Arthritis 16%
• Symptom Resolution 16%
• Living with 16%
• Final Diagnosis 16%
• Best Response 16%
• Lymphopenia 16%
• Direct Therapy 16%
• Refractory Disease 16%
• Injection Drug Use 16%
• Systemic Chemotherapy 16%
• HIV Screening 16%
• Persistent Symptoms 16%
• Patient-initiated 16%
• Infliximab Therapy 16%
• Cutaneous Involvement 16%
• Inflammatory Bowel Disease Arthritis 16%
• Visceral Involvement 16%
• HIV-associated Kaposi Sarcoma 16%
• Methotrexate Treatment 16%

Medicine and Dentistry

• Tumor Necrosis Factor 100%
• Human Immunodeficiency Virus Infection 100%
• HIV Test 85%
• Symptom 42%
• Human Immunodeficiency Virus 42%
• T-Helper Cell 42%
• Immunosuppressive Treatment 42%
• Inflammatory Bowel Disease 42%
• Antiretroviral Therapy 42%
• Cell Count 42%
• Kaposi Sarcoma 42%
• Hidradenitis Suppurativa 42%
• Biological Product 28%
• Rheumatoid Arthritis 28%
• Methotrexate 28%
• Biological Therapy 28%
• Infliximab 28%
• Epileptic Absence 14%
• Disease 14%
• Immune Reconstitution Inflammatory Syndrome 14%
• Arthropathy 14%
• Drug Use 14%
• Final Diagnosis 14%
• Lymphocytopenia 14%
• Adalimumab 14%
• Rheumatic Disorder 14%

Immunology and Microbiology

• Tumor Necrosis Factor 100%
• Human Immunodeficiency Virus 100%
• Human Immunodeficiency Virus Infection 100%
• Immunosuppression 33%
• Inflammatory Bowel Disease 33%
• Biological Product 33%
• CD4 Lymphocyte Count 33%
• Hidradenitis Suppurativa 33%
• Inflammatory Arthritis 22%
• Methotrexate 22%
• Infliximab 22%
• Immune Reconstitution Inflammatory Syndrome 11%
• Arthropathy 11%
• Lymphocytopenia 11%
• Adalimumab 11%